Insider Transactions in Q4 2025 at New Amsterdam Pharma CO N.V. (NAMS)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 26 2025	Louise Frederika Kooij Chief Accounting Officer	SELL Open market or private sale	Direct	43,872 -74.52%	$1,535,520 $35.3 P/Share
Dec 26 2025	Louise Frederika Kooij Chief Accounting Officer	BUY Exercise of conversion of derivative security	Direct	43,872 +24.87%	$438,720 $10.45 P/Share
Dec 24 2025	Louise Frederika Kooij Chief Accounting Officer	SELL Open market or private sale	Direct	26,011 -63.42%	$910,385 $35.68 P/Share

Dec 24 2025	Louise Frederika Kooij Chief Accounting Officer	BUY Exercise of conversion of derivative security	Direct	26,011 +38.81%	$260,110 $10.0 P/Share
Dec 23 2025	Louise Frederika Kooij Chief Accounting Officer	SELL Open market or private sale	Direct	75,117 -83.36%	$2,704,212 $36.21 P/Share
Dec 23 2025	Louise Frederika Kooij Chief Accounting Officer	BUY Exercise of conversion of derivative security	Direct	75,117 +45.46%	$751,170 $10.0 P/Share

Receive a notification when an Institution or Guru buys or sells NAMS shares.

Notify only if

Value

Get notified when an New Amsterdam Pharma CO N.V. insider buys or sells NAMS shares.

Notify only if

Operation

Value

Type

Receive news related to NewAmsterdam Pharma Co N.V.